Y216C (p.Tyr216Cys) variant of ITGB3 (Integrin beta-3)

Y216C (p.Tyr216Cys) in ITGB3 (Integrin beta-3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Glanzmann thrombasthenia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.94 / 1. The record also includes structural context.

Y216C (p.Tyr216Cys) variant details